urovestВестник урологииUrology Herald2308-6424Rostov State Medical University10.21886/2308-6424-2026-14-3-76-85urovest-1244Research ArticleОБЗОРЫ ЛИТЕРАТУРЫREVIEWS ARTICLEВозможности реабилитации пациентов с различными типами недержания мочи после трансуретральных вмешательств по поводу гиперплазии предстательной железыRehabilitation options for patients with different types of urinary incontinence following transurethral surgery for benign prostatic hyperplasiahttps://orcid.org/0009-0004-0780-6995МещеряковаЕ. А.MeshcheriakovaE. A.

Елена Александровна Мещерякова

Москва

Elena A. Meshcheriakova

Moscow

elenastrepetova03@gmail.comhttps://orcid.org/0009-0000-9807-5171НевольниковД. Ю.NevolnikovD. Yu.

Дмитрий Юрьевич Невольников

Москва

Dmitrii Yu. Nevolnikov

Moscow

dnevolnikoff@gmail.comhttps://orcid.org/0000-0003-3355-4547НестероваО. Ю.NesterovaO. Yu.

Ольга Юрьевна Нестерова — канд. мед. наук

Москва

Olga Yu. Nesterova — Cand.Sc.(Med)

Moscow

oy.nesterova@gmail.comhttps://orcid.org/0000-0003-4518-634XСтригуновА. А.StrigunovA. A.

Андрей Алексеевич Стригунов — канд. мед. наук 

Москва

Andrey A. Strigunov — Cand.Sc.(Med)

Moscow

an-strigunov@yandex.ruhttps://orcid.org/0000-0002-3208-4697НиколаевМ. Ю.NikolaevM. Yu.

Михаил Юрьевич Николаев

Москва

Mikhail Yu. Nikolaev

Moscow

Mikhail.nikolaev01@bk.ruhttps://orcid.org/0009-0007-8276-925XЮсуповК. М.YusupovK. M.

Карим Маратович Юсупов

Москва

Karim M. Yusupov

Moscow

sefender1122@gmail.comhttps://orcid.org/0000-0002-6768-9004ОхоботовД. А.OkhobotovD. A.

Дмитрий Александрович Охоботов — д-р мед. наук 

Москва

Dmitry A. Okhobotov — Dr.Sc.(Med)

Moscow

14072003m@mail.ruhttps://orcid.org/0000-0001-9466-7567СорокинН. И.SorokinN. I.

Николай Иванович Сорокин — д-р мед. наук 

Москва

Nikolay I. Sorokin — Dr.Sc.(Med)

Moscow

nisorokin@mail.ruhttps://orcid.org/0000-0003-4251-7545КамаловА. А.KamalovA. A.

Армаис Альбертович Камалов — д-р мед. наук, профессор, академик РАН 

Москва

Armais A. Kamalov — Dr.Sc.(Med), Full Prof., Acad. of the RAS

Moscow

armais.kamalov@rambler.ruМосковский государственный университет им. М.В. ЛомоносоваРоссияLomonosov Moscow State University (Lomonosov University)Russian Federation2026080820261437685Copyright © Мещерякова Е.А., Невольников Д.Ю., Нестерова О.Ю., Стригунов А.А., Николаев М.Ю., Юсупов К.М., Охоботов Д.А., Сорокин Н.И., Камалов А.А., 20262026Мещерякова Е.А., Невольников Д.Ю., Нестерова О.Ю., Стригунов А.А., Николаев М.Ю., Юсупов К.М., Охоботов Д.А., Сорокин Н.И., Камалов А.А.Meshcheriakova E.A., Nevolnikov D.Y., Nesterova O.Y., Strigunov A.A., Nikolaev M.Y., Yusupov K.M., Okhobotov D.A., Sorokin N.I., Kamalov A.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.urovest.ru/jour/article/view/1244Введение

Введение. Трансуретральная резекция простаты (ТУРП) остаётся «золотым стандартом» оперативного лечения пациентов с гиперплазией предстательной железы (ГПЖ), при этом всё большую популярность набирают различные методики эндоскопической энуклеации. Однако, несмотря на все преимущества минимально инвазивного трансуретрального подхода, одним из наиболее значимых и нежелательных послеоперационных осложнений остаётся недержание мочи, которое может развиваться в послеоперационном периоде и существенно нарушать повседневную активность.

Цель исследования

Цель исследования. Оценить возможности лечения недержания мочи  после  трансуретральных  операций по поводу ГПЖ.

Материалы и методы

Материалы и методы. Проведён обзор электронных баз PubMed и Elibrary.ru с 1999 по 2026 год, чтобы выявить все соответствующие исследования. Электронный поиск был ограничен русским и английским языком.

Результаты

Результаты. После трансуретральных вмешательств по поводу ГПЖ могут развиваться различные типы недержания мочи: ургентное, стрессовое и смешанное. Оценка частоты недержания после трансуретральных вмешательств при ГПЖ в литературе неоднозначна и варьируется от 0,5 до 60%. Такой большой разброс говорит об отсутствии единого понимания и подхода к диагностике данного осложнения. В терапии ургентного недержания мочи после трансуретральных операций по поводу ГПЖ используется комплексный поход, включающий противовоспалительные и антибактериальные препараты, М-холиноблокаторы, агонисты бета3-адренорецепторов, в более тяжёлых случаях — внутридетрузорные инъекции ботулотоксина. В терапии стрессового недержания мочи, связанного с трансуретральным доступом при ГПЖ, используются в первую очередь упражнения для укрепления мышц тазового дна (в частности с биологической обратной связью, магнитной или электрической стимуляцией). В более тяжёлых случаях прибегают к хирургическим методикам — установке слинга или искусственного сфинктера.

Заключение

Заключение. Тренировки мышц тазового дна являются одним из наиболее перспективных методов лечения недержания мочи после трансуретральных операций по поводу ГПЖ. Тем не менее данный вопрос требует дальнейшего изучения и уточнения в силу недостатка данных, что не позволяет в полной мере судить об эффективности, безопасности и взаимовлиянии разных методов реабилитации при недержании мочи после трансуретральных вмешательств у мужчин.

Introduction

Introduction. Transurethral resection of the prostate (TURP) remains the gold standard surgical treatment for benign prostatic hyperplasia (BPH), while various endoscopic enucleation techniques are gaining increasing popularity. Despite the advantages of the minimally invasive transurethral approach, urinary incontinence (UI) remains one of the most significant and undesirable postoperative complications, potentially developing in the postoperative period and substantially impairing daily activities.

Objective

Objective. To evaluate treatment options for UI following transurethral surgery for BPH.

Materials & methods

Materials & methods. A systematic review of the PubMed and Elibrary.ru databases was conducted for the period from 1999 to 2026 to identify all relevant studies. The search was limited to publications in Russian and English.

Results

Results. Following transurethral surgery for BPH, various UI types may develop, including urge, stress, and mixed incontinence. Reported rates of UI after transurethral procedures for BPH vary considerably across the literature, ranging from 0.5% to 60%. This wide variability reflects the lack of a unified definition and diagnostic approach to this  complication.  Management  of  urge  urinary  incontinence  after  transurethral  surgery  for  BPH  involves a multimodal approach, including anti-inflammatory and antibacterial agents, antimuscarinics, and beta-3 adrenergic receptor agonists; in more severe cases, intradetrusor botulinum toxin injections are employed. For stress urinary incontinence (SUI) associated with the transurethral approach in BPH, first-line therapy consists of pelvic floor muscle training (including biofeedback-guided exercises, magnetic or electrical stimulation). In more severe cases, surgical interventions are considered, such as sling placement or artificial urinary sphincter implantation.

Conclusion

Conclusion. Pelvic floor muscle training represents one of the most promising treatment modalities for UI following transurethral surgery for BPH. However, further research is needed to clarify optimal rehabilitation strategies, as current evidence remains insufficient to fully assess the efficacy, safety, and potential interactions of different treatment approaches for post-transurethral incontinence in men.

гиперплазия простатытрансуретральная резекция гиперплазии простатыэндоскопическая энуклеация гиперплазии простатыстрессовое недержание мочиургентное недержание мочитренировки мышц тазового днаbenign prostatic hyperplasiatransurethral resection of prostate hyperplasiaendoscopic enucleation of prostate hyperplasiastress urinary incontinenceurgent urinary incontinencepelvic floor muscle trainingИсследование выполнено в рамках государственного задания ФГБОУ ВО «МГУ им. М.В. Ломоносова» (0908)The study was conducted under the State Assignment of Lomonosov Moscow State University (0908)ReferencesVasanwala F.F., Wong M.Y.C., Ho H.S.S., Foo K.T. Benign prostatic hyperplasia and male lower urinary symptoms: A guide for family physicians. Asian Journal of Urology. 2017;4(3):181-184. DOI: 10.1016/j.ajur.2017.05.003Vasanwala F.F., Wong M.Y.C., Ho H.S.S., Foo K.T. Benign prostatic hyperplasia and male lower urinary symptoms: A guide for family physicians. Asian Journal of Urology. 2017;4(3):181-184. DOI: 10.1016/j.ajur.2017.05.003Egan K.B. The Epidemiology of Benign Prostatic Hyperplasia Associated with Lower Urinary Tract Symptoms: Prevalence and Incident Rates. Urol Clin North Am. 2016;43(3):289-297. DOI: 10.1016/j.ucl.2016.04.001Egan K.B. The Epidemiology of Benign Prostatic Hyperplasia Associated with Lower Urinary Tract Symptoms: Prevalence and Incident Rates. Urol Clin North Am. 2016;43(3):289-297. DOI: 10.1016/j.ucl.2016.04.001Vos T., Flaxman A.D., Naghavi M., Lozano R., Michaud C., Ezzati M., Shibuya K., SalomonJ.A., Abdalla S., Aboyans V., Abraham J., Ackerman I., Aggarwal R., AhnS.Y., Ali M.K., Alvarado M., Anderson H.R., Anderson L.M., Andrews K.G., Atkinson C., Baddour L.M., Bahalim A.N., Barker-Collo S., Barrero L.H., Bartels D.H., Basáñez M.G., Baxter A., Bell M.L., Benjamin E.J., Bennett D., Bernabé E., Bhalla K., Bhandari B., Bikbov B., Bin Abdulhak A., Birbeck G., Black J.A., Blencowe H., Blore J.D., Blyth F., Bolliger I., Bonaventure A., Boufous S., Bourne R., Boussinesq M., Braithwaite T., Brayne C., Bridgett L., Brooker S., Brooks P., Brugha T.S., Bryan-Hancock C., Bucello C., Buchbinder R., Buckle G., Budke C.M., Burch M., Burney P., Burstein R., Calabria B., Campbell B., Canter C.E., Carabin H., Carapetis J., Carmona L., Cella C., Charlson F., Chen H., Cheng A.T., Chou D., Chugh S.S., Coffeng L.E., Colan S.D., Colquhoun S., Colson K.E., Condon J., Connor M.D., Cooper L.T., CorriereM., Cortinovis M., de Vaccaro K.C., CouserW., Cowie B.C., Criqui M.H., Cross M., Dabhadkar K.C., Dahiya M., Dahodwala N., Damsere-Derry J., Danaei G., Davis A., De Leo D., Degenhardt L., Dellavalle R., Delossantos A., Denenberg J., Derrett S., Des Jarlais D.C., Dharmaratne S.D., Dherani M., Diaz-Torne C., Dolk H., Dorsey E.R., Driscoll T., Duber H., Ebel B., Edmond K., Elbaz A., Ali S.E., Erskine H., Erwin P.J., Espindola P., Ewoigbokhan S.E., Farzadfar F., Feigin V., Felson D.T., Ferrari A., Ferri C.P., Fèvre E.M., Finucane M.M., Flaxman S., Flood L., Foreman K., Forouzanfar M.H., Fowkes F.G., Franklin R., Fransen M., Freeman M.K., Gabbe B.J., Gabriel S.E., Gakidou E., Ganatra H.A., Garcia B., Gaspari F., Gillum R.F., Gmel G., Gosselin R., Grainger R., Groeger J., Guillemin F., Gunnell D., Gupta R., Haagsma J., Hagan H., Halasa Y.A., Hall W., Haring D., Haro J.M., Harrison J.E., Havmoeller R., Hay R.J., Higashi H., Hill C., Hoen B., Hoffman H., Hotez P.J., Hoy D., Huang J.J., Ibeanusi S.E., Jacobsen K.H., James S.L., Jarvis D., Jasrasaria R., Jayaraman S., Johns N., Jonas J.B., Karthikeyan G., Kassebaum N., Kawakami N., Keren A., Khoo J.P., King C.H., Knowlton L.M., Kobusingye O., Koranteng A., Krishnamurthi R., Lalloo R., Laslett L.L., Lathlean T., LeasherJ.L., Lee Y.Y., Leigh J., Lim S.S., Limb E., Lin J.K., Lipnick M., Lipshultz S.E., Liu W., Loane M., Ohno S.L., Lyons R., Ma J., Mabweijano J., MacIntyre M.F., Malekzadeh R., Mallinger L., Manivannan S., Marcenes W., March L., Margolis D.J., Marks G.B., Marks R., Matsumori A., Matzopoulos R., Mayosi B.M., McAnulty J.H., McDermott M.M., McGill N., McGrath J., Medina-Mora M.E., Meltzer M., Mensah G.A., Merriman T.R., Meyer A.C., Miglioli V., Miller M., Miller T.R., Mitchell P.B., Mocumbi A.O., Moffitt T.E., Mokdad A.A., Monasta L., Montico M., Moradi-Lakeh M., Moran A., Morawska L., Mori R., Murdoch M.E., Mwaniki M.K., Naidoo K., Nair M.N., Naldi L., Narayan K.M., Nelson P.K., Nelson R.G., Nevitt M.C., Newton C.R., Nolte S., Norman P., Norman R., O’Donnell M., O’Hanlon S., Olives C., Omer S.B., Ortblad K., Osborne R., Ozgediz D., Page A., Pahari B., Pandian J.D., Rivero A.P., Patten S.B., Pearce N., Padilla R.P., Perez-Ruiz F., Perico N., Pesudovs K., Phillips D., Phillips M.R., Pierce K., Pion S., Polanczyk G.V., Polinder S., Pope CA 3rd, Popova S., Porrini E., Pourmalek F., Prince M., Pullan R.L., Ramaiah K.D., Ranganathan D., Razavi H., Regan M., Rehm J.T., Rein D.B., Remuzzi G., Richardson K., Rivara F.P., Roberts T., Robinson C., De Leòn F.R., Ronfani L., Room R., Rosenfeld L.C., Rushton L., Sacco R.L., Saha S., Sampson U., Sanchez-Riera L., Sanman E., Schwebel D.C., Scott J.G., Segui-Gomez M., Shahraz S., Shepard D.S., Shin H., Shivakoti R., Singh D., Singh G.M., Singh J.A., Singleton J., Sleet D.A., Sliwa K., Smith E., Smith J.L., Stapelberg N.J., Steer A., Steiner T., Stolk W.A., Stovner L.J., Sudfeld C., Syed S., Tamburlini G., Tavakkoli M., Taylor H.R., Taylor J.A., Taylor W.J., Thomas B., Thomson W.M., Thurston G.D., Tleyjeh I.M., Tonelli M., Towbin J.A., Truelsen T., Tsilimbaris M.K., Ubeda C., Undurraga E.A., van der Werf M.J., van Os J., Vavilala M.S., Venketasubramanian N., Wang M., Wang W., Watt K., Weatherall D.J., Weinstock M.A., Weintraub R., Weisskopf M.G., Weissman M.M., White R.A., Whiteford H., Wiersma S.T., Wilkinson J.D., Williams H.C., Williams S.R., Witt E., Wolfe F., Woolf A.D., Wulf S., Yeh P.H., Zaidi A.K., Zheng Z.J., Zonies D., Lopez A.D., Murray C.J., AlMazroa M.A., Memish Z.A. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2163-2196. DOI: 10.1016/S0140-6736(12)61729-2Vos T., Flaxman A.D., Naghavi M., Lozano R., Michaud C., Ezzati M., Shibuya K., SalomonJ.A., Abdalla S., Aboyans V., Abraham J., Ackerman I., Aggarwal R., AhnS.Y., Ali M.K., Alvarado M., Anderson H.R., Anderson L.M., Andrews K.G., Atkinson C., Baddour L.M., Bahalim A.N., Barker-Collo S., Barrero L.H., Bartels D.H., Basáñez M.G., Baxter A., Bell M.L., Benjamin E.J., Bennett D., Bernabé E., Bhalla K., Bhandari B., Bikbov B., Bin Abdulhak A., Birbeck G., Black J.A., Blencowe H., Blore J.D., Blyth F., Bolliger I., Bonaventure A., Boufous S., Bourne R., Boussinesq M., Braithwaite T., Brayne C., Bridgett L., Brooker S., Brooks P., Brugha T.S., Bryan-Hancock C., Bucello C., Buchbinder R., Buckle G., Budke C.M., Burch M., Burney P., Burstein R., Calabria B., Campbell B., Canter C.E., Carabin H., Carapetis J., Carmona L., Cella C., Charlson F., Chen H., Cheng A.T., Chou D., Chugh S.S., Coffeng L.E., Colan S.D., Colquhoun S., Colson K.E., Condon J., Connor M.D., Cooper L.T., CorriereM., Cortinovis M., de Vaccaro K.C., CouserW., Cowie B.C., Criqui M.H., Cross M., Dabhadkar K.C., Dahiya M., Dahodwala N., Damsere-Derry J., Danaei G., Davis A., De Leo D., Degenhardt L., Dellavalle R., Delossantos A., Denenberg J., Derrett S., Des Jarlais D.C., Dharmaratne S.D., Dherani M., Diaz-Torne C., Dolk H., Dorsey E.R., Driscoll T., Duber H., Ebel B., Edmond K., Elbaz A., Ali S.E., Erskine H., Erwin P.J., Espindola P., Ewoigbokhan S.E., Farzadfar F., Feigin V., Felson D.T., Ferrari A., Ferri C.P., Fèvre E.M., Finucane M.M., Flaxman S., Flood L., Foreman K., Forouzanfar M.H., Fowkes F.G., Franklin R., Fransen M., Freeman M.K., Gabbe B.J., Gabriel S.E., Gakidou E., Ganatra H.A., Garcia B., Gaspari F., Gillum R.F., Gmel G., Gosselin R., Grainger R., Groeger J., Guillemin F., Gunnell D., Gupta R., Haagsma J., Hagan H., Halasa Y.A., Hall W., Haring D., Haro J.M., Harrison J.E., Havmoeller R., Hay R.J., Higashi H., Hill C., Hoen B., Hoffman H., Hotez P.J., Hoy D., Huang J.J., Ibeanusi S.E., Jacobsen K.H., James S.L., Jarvis D., Jasrasaria R., Jayaraman S., Johns N., Jonas J.B., Karthikeyan G., Kassebaum N., Kawakami N., Keren A., Khoo J.P., King C.H., Knowlton L.M., Kobusingye O., Koranteng A., Krishnamurthi R., Lalloo R., Laslett L.L., Lathlean T., LeasherJ.L., Lee Y.Y., Leigh J., Lim S.S., Limb E., Lin J.K., Lipnick M., Lipshultz S.E., Liu W., Loane M., Ohno S.L., Lyons R., Ma J., Mabweijano J., MacIntyre M.F., Malekzadeh R., Mallinger L., Manivannan S., Marcenes W., March L., Margolis D.J., Marks G.B., Marks R., Matsumori A., Matzopoulos R., Mayosi B.M., McAnulty J.H., McDermott M.M., McGill N., McGrath J., Medina-Mora M.E., Meltzer M., Mensah G.A., Merriman T.R., Meyer A.C., Miglioli V., Miller M., Miller T.R., Mitchell P.B., Mocumbi A.O., Moffitt T.E., Mokdad A.A., Monasta L., Montico M., Moradi-Lakeh M., Moran A., Morawska L., Mori R., Murdoch M.E., Mwaniki M.K., Naidoo K., Nair M.N., Naldi L., Narayan K.M., Nelson P.K., Nelson R.G., Nevitt M.C., Newton C.R., Nolte S., Norman P., Norman R., O’Donnell M., O’Hanlon S., Olives C., Omer S.B., Ortblad K., Osborne R., Ozgediz D., Page A., Pahari B., Pandian J.D., Rivero A.P., Patten S.B., Pearce N., Padilla R.P., Perez-Ruiz F., Perico N., Pesudovs K., Phillips D., Phillips M.R., Pierce K., Pion S., Polanczyk G.V., Polinder S., Pope CA 3rd, Popova S., Porrini E., Pourmalek F., Prince M., Pullan R.L., Ramaiah K.D., Ranganathan D., Razavi H., Regan M., Rehm J.T., Rein D.B., Remuzzi G., Richardson K., Rivara F.P., Roberts T., Robinson C., De Leòn F.R., Ronfani L., Room R., Rosenfeld L.C., Rushton L., Sacco R.L., Saha S., Sampson U., Sanchez-Riera L., Sanman E., Schwebel D.C., Scott J.G., Segui-Gomez M., Shahraz S., Shepard D.S., Shin H., Shivakoti R., Singh D., Singh G.M., Singh J.A., Singleton J., Sleet D.A., Sliwa K., Smith E., Smith J.L., Stapelberg N.J., Steer A., Steiner T., Stolk W.A., Stovner L.J., Sudfeld C., Syed S., Tamburlini G., Tavakkoli M., Taylor H.R., Taylor J.A., Taylor W.J., Thomas B., Thomson W.M., Thurston G.D., Tleyjeh I.M., Tonelli M., Towbin J.A., Truelsen T., Tsilimbaris M.K., Ubeda C., Undurraga E.A., van der Werf M.J., van Os J., Vavilala M.S., Venketasubramanian N., Wang M., Wang W., Watt K., Weatherall D.J., Weinstock M.A., Weintraub R., Weisskopf M.G., Weissman M.M., White R.A., Whiteford H., Wiersma S.T., Wilkinson J.D., Williams H.C., Williams S.R., Witt E., Wolfe F., Woolf A.D., Wulf S., Yeh P.H., Zaidi A.K., Zheng Z.J., Zonies D., Lopez A.D., Murray C.J., AlMazroa M.A., Memish Z.A. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2163-2196. DOI: 10.1016/S0140-6736(12)61729-2Foé C.M.E., Liao Y., Zhang G. A Review on Urinary Incontinence after Surgery for Benign Prostatic Hyperplasia. OJU. 2022;12(03):169-184. DOI: 10.4236/oju.2021.123017Foé C.M.E., Liao Y., Zhang G. A Review on Urinary Incontinence after Surgery for Benign Prostatic Hyperplasia. OJU. 2022;12(03):169-184. DOI: 10.4236/oju.2021.123017Aybal H.C., Yilmaz M., Barlas I.S., Duvarci M., Tuncel A., Tunc L. Comparison of HoLEP, ThuLEP and ThuFLEP in the treatment of benign prostatic obstruction: a propensity score-matched analysis. World J Urol. 2024;42(1):374. DOI: 10.1007/s00345-024-05082-2Aybal H.C., Yilmaz M., Barlas I.S., Duvarci M., Tuncel A., Tunc L. Comparison of HoLEP, ThuLEP and ThuFLEP in the treatment of benign prostatic obstruction: a propensity score-matched analysis. World J Urol. 2024;42(1):374. DOI: 10.1007/s00345-024-05082-2Bucca B., Gozzi C., Gobbi L.M., Bologna E., Licari L.C., Asero V., Dalpiaz O., Alber T., Calarco A., Martini M., Presicce F. The dark side of transurethral access for LUTS/BPH surgery: a narrative review. Asian J Androl. 2026;28(1):46-56. DOI: 10.4103/aja202523Bucca B., Gozzi C., Gobbi L.M., Bologna E., Licari L.C., Asero V., Dalpiaz O., Alber T., Calarco A., Martini M., Presicce F. The dark side of transurethral access for LUTS/BPH surgery: a narrative review. Asian J Androl. 2026;28(1):46-56. DOI: 10.4103/aja202523Волков С.Н., Пушкарь Д.Ю., Колонтарев К.Б., Степанченко В.С., Терещенко В.И., Джаримок А.Р., Шевякина А.Е., Дауров М.А. Выраженность симптомов нижних мочевых путей в послеоперационном периоде как фактор выбора подхода к хирургическому лечению гиперплазии простаты больших размеров: гольмиевая энуклеация предстательной железы и лапароскопическая позадилонная аденомэктомия. Вестник урологии. 2024;12(2):5-14. DOI: 10.21886/2308-6424-2024-12-2-5-14Volkov S.N., Pushkar D.Yu., Kolontarev K.B., Stepanchenko V.S., Tereshchenko V.I., Dzharimok A.R., Shevyakina A.E., Daurov M.A. The severity of lower urinary tract symptoms during the postoperative period as a factor in choosing an approach to surgical treatment for large prostate hyperplasia: holmium enucleation of the prostate (HoLEP) vs laparoscopic simple prostatectomy. Urology Herald. 2024;12(2):5-14. (In Russian). DOI: 10.21886/2308-6424-2024-12-2-5-14Мартов А.Г., Меринов Д.С., Корниенко С.И., Гущин Б.Л., Ергаков Д.В., Мустафаев Э.М., Борисенко Е.А. Послеоперационные урологические осложнения трансуретральных электрохирургических вмешательств на предстательной железе по поводу аденомы. Урология. 2006;(2):25-32. PMID: 16708585Martov A.G., Merinov D.S., Kornienko S.I., Gushchin B.L., Ergakov D.V., Mustafaev E.M., Borisenko EA. [Postoperative urological complications of transurethral electrosurgical interventions on the prostate for adenoma]. Urologiia. 2006;(2):25-32. (In Russian). PMID: 16708585Круглов В.А., АсфандияровФ.Р., Сеидов К.С., Офлиди К.Г., Алиев Р.Т., Мурзагалиева А.Н., Хиджи М.Ф., Валитова Э.Х. Консервативное лечение недержания мочи после трансуретральной резекции доброкачественной гиперплазии предстательной железы. Экспериментальная и клиническая урология. 2023;16(1):90-98. DOI: 10.29188/2222-8543-2023-16-1-90-98Kruglov V.A., Asfandiyarov F.R., Seidov K.S., Oflidi K.G., Aliev R.T., Murzagalieva A.N., Hiji M.F., Valitova E.Kh. Conservative treatment of urinary incontinence after transurethral resection of the prostate. Experimental and Clinical Urology. 2023;16(1):90-98. (In Russian). DOI: 10.29188/2222-8543-2023-16-1-90-98Yang M., Huang Y., Gao F., He L., Yu X., Yu Q. Meta-analysis of postoperative urinary incontinence incidence and risk factors in HoLEP. Ther Adv Urol. 2024;16:17562872241281578. DOI: 10.1177/17562872241281578Yang M., Huang Y., Gao F., He L., Yu X., Yu Q. Meta-analysis of postoperative urinary incontinence incidence and risk factors in HoLEP. Ther Adv Urol. 2024;16:17562872241281578. DOI: 10.1177/17562872241281578Castellani D., Rubilotta E., Fabiani A., Maggi M., Wroclawski M.L., Teoh J.Y., Pirola G.M., Gubbiotti M., Pavia M.P., Gomez-Sancha F., Galosi A.B., Gauhar V. Correlation Between Transurethral Interventions and Their Influence on Type and Duration of Postoperative Urinary Incontinence: Results from a Systematic Review and Meta-Analysis of Comparative Studies. J Endourol. 2022;36(10):1331-1347. DOI: 10.1089/end.2022.0222Castellani D., Rubilotta E., Fabiani A., Maggi M., Wroclawski M.L., Teoh J.Y., Pirola G.M., Gubbiotti M., Pavia M.P., Gomez-Sancha F., Galosi A.B., Gauhar V. Correlation Between Transurethral Interventions and Their Influence on Type and Duration of Postoperative Urinary Incontinence: Results from a Systematic Review and Meta-Analysis of Comparative Studies. J Endourol. 2022;36(10):1331-1347. DOI: 10.1089/end.2022.0222He M., Mao C., Shu Y., Liu X. Urinary Incontinence Following Transurethral Prostatectomy: Current Status and Nursing Strategies. Biol Res Nurs. 2025;27(3):423-429. DOI: 10.1177/10998004251318909He M., Mao C., Shu Y., Liu X. Urinary Incontinence Following Transurethral Prostatectomy: Current Status and Nursing Strategies. Biol Res Nurs. 2025;27(3):423-429. DOI: 10.1177/10998004251318909Blackburn S.C., Jones C., Bedoya S., Steinbrecher H.A., Malone P.S., Griffin S.J. Intravesical botulinum type-A toxin (Dysport®) in the treatment of idiopathic detrusor overactivity in children. J Pediatr Urol. 2013;9(6 Pt A):750-753. DOI: 10.1016/j.jpurol.2012.08.011Blackburn S.C., Jones C., Bedoya S., Steinbrecher H.A., Malone P.S., Griffin S.J. Intravesical botulinum type-A toxin (Dysport®) in the treatment of idiopathic detrusor overactivity in children. J Pediatr Urol. 2013;9(6 Pt A):750-753. DOI: 10.1016/j.jpurol.2012.08.011Das A.K., Teplitsky S., Chandrasekar T., Perez T., Guo J., Leong J.Y., Shenot P.J. Stress Urinary Incontinence post-Holmium Laser Enucleation of the Prostate: a Single-Surgeon Experience. Int Braz J Urol. 2020;46(4):624-631. DOI: 10.1590/S1677-5538.IBJU.2019.0411Das A.K., Teplitsky S., Chandrasekar T., Perez T., Guo J., Leong J.Y., Shenot P.J. Stress Urinary Incontinence post-Holmium Laser Enucleation of the Prostate: a Single-Surgeon Experience. Int Braz J Urol. 2020;46(4):624-631. DOI: 10.1590/S1677-5538.IBJU.2019.0411Huang H.N., Sun Y.H., Liu X., Tao W.Q. Analysis of Postoperative Urinary Incontinence and Influencing Factors of Transurethral Holmium Laser Enucleation of the Prostate. Urol Int. 2024;108(5):457-463. DOI: 10.1159/000539201Huang H.N., Sun Y.H., Liu X., Tao W.Q. Analysis of Postoperative Urinary Incontinence and Influencing Factors of Transurethral Holmium Laser Enucleation of the Prostate. Urol Int. 2024;108(5):457-463. DOI: 10.1159/000539201Coman R.A., Bschleipfer T., Al Hajjar N., Petrut B. Predictive Factors of Transient Urinary Incontinence Following Holmium Laser Enucleation of the Prostate (HoLEP): Single-Center Experience. Medicina (Kaunas). 2024;60(9):1460. DOI: 10.3390/medicina60091460Coman R.A., Bschleipfer T., Al Hajjar N., Petrut B. Predictive Factors of Transient Urinary Incontinence Following Holmium Laser Enucleation of the Prostate (HoLEP): Single-Center Experience. Medicina (Kaunas). 2024;60(9):1460. DOI: 10.3390/medicina60091460Коган М.И. Коррекция недержания мочи у мужчин и женщин. Вестник урологии. 2024;12(3):5-9. DOI: 10.21886/2308-6424-2024-12-3-5-9Kogan M.I. Male and female urinary incontinence management. Urology Herald. 2024;12(3):5-9. (In Russian). DOI: 10.21886/2308-6424-2024-12-3-5-9Богданов Д.А., Юсуфов А.Г., Гуспанов Р.И., Котов С.В. Результаты лечения гиперактивного мочевого пузыря после оперативных вмешательств по поводу гиперплазии предстательной железы в реальной клинической практике. Вестник урологии. 2025;13(3):19- 29. DOI: 10.21886/2308-6424-2025-13-3-19-29Bogdanov D.A., Yusufov A.G., Guspanov R.I., Kotov S.V. Overactive bladder following surgical intervention for benign prostatic hyperplasia: treatment outcomes in routine clinical practice. Urology Herald. 2025;13(3):19-29. (In Russian). DOI: 10.21886/2308-6424-2025-13-3-19-29Shah H.N., Mahajan A.P., Hegde S.S., Bansal M.B. Peri-operative complications of holmium laser enucleation of the prostate: experience in the first 280 patients, and a review of literature. BJU Int. 2007;100(1):94- 101. DOI: 10.1111/j.1464-410X.2007.06867.xShah H.N., Mahajan A.P., Hegde S.S., Bansal M.B. Peri-operative complications of holmium laser enucleation of the prostate: experience in the first 280 patients, and a review of literature. BJU Int. 2007;100(1):94- 101. DOI: 10.1111/j.1464-410X.2007.06867.xVavassori I., Hurle R., Vismara A., Manzetti A., Valenti S. Holmium laser enucleation of the prostate combined with mechanical morcellation: two years of experience with 196 patients. J Endourol. 2004;18(1):109- 112. DOI: 10.1089/089277904322836767Vavassori I., Hurle R., Vismara A., Manzetti A., Valenti S. Holmium laser enucleation of the prostate combined with mechanical morcellation: two years of experience with 196 patients. J Endourol. 2004;18(1):109- 112. DOI: 10.1089/089277904322836767Lee H.Y., Cho S.Y., Juan Y.S., Teoh J.Y. How to optimise urinary continence in anatomical endoscopic enucleation of the prostate? Andrologia. 2020;52(8):e13621. DOI: 10.1111/and.13621Lee H.Y., Cho S.Y., Juan Y.S., Teoh J.Y. How to optimise urinary continence in anatomical endoscopic enucleation of the prostate? Andrologia. 2020;52(8):e13621. DOI: 10.1111/and.13621Nam J.K., Kim H.W., Lee D.H., Han J.Y., Lee J.Z., Park S.W. Risk Factors for Transient Urinary Incontinence after Holmium Laser Enucleation of the Prostate. World J Mens Health. 2015;33(2):88-94. DOI: 10.5534/wjmh.2015.33.2.88Nam J.K., Kim H.W., Lee D.H., Han J.Y., Lee J.Z., Park S.W. Risk Factors for Transient Urinary Incontinence after Holmium Laser Enucleation of the Prostate. World J Mens Health. 2015;33(2):88-94. DOI: 10.5534/wjmh.2015.33.2.88Cho M.C., Park J.H., Jeong M.S., Yi J.S., Ku J.H., Oh S.J., Kim S.W., Paick J.S. Predictor of de novo urinary incontinence following holmium laser enucleation of the prostate. Neurourol Urodyn. 2011;30(7):1343-1349. DOI: 10.1002/nau.21050Cho M.C., Park J.H., Jeong M.S., Yi J.S., Ku J.H., Oh S.J., Kim S.W., Paick J.S. Predictor of de novo urinary incontinence following holmium laser enucleation of the prostate. Neurourol Urodyn. 2011;30(7):1343-1349. DOI: 10.1002/nau.21050Leach G.E., Trockman B., Wong A., Hamilton J., Haab F., Zimmern P.E. Post-prostatectomy incontinence: urodynamic findings and treatment outcomes. J Urol. 1996;155(4):1256-1259. DOI: 10.1016/s0022-5347(01)66235-9Leach G.E., Trockman B., Wong A., Hamilton J., Haab F., Zimmern P.E. Post-prostatectomy incontinence: urodynamic findings and treatment outcomes. J Urol. 1996;155(4):1256-1259. DOI: 10.1016/s0022-5347(01)66235-9Dorey G. A clinical overview of the treatment of post-prostatectomy incontinence. Br J Nurs. 2007;16(19):1194-1199. DOI: 10.12968/bjon.2007.16.19.27357Dorey G. A clinical overview of the treatment of post-prostatectomy incontinence. Br J Nurs. 2007;16(19):1194-1199. DOI: 10.12968/bjon.2007.16.19.27357Anderson C.A., Omar M.I., Campbell S.E., Hunter K.F., Cody J.D., Glazener C.M. Conservative management for postprostatectomy urinary incontinence. Cochrane Database Syst Rev. 2015;1(1):CD001843. DOI: 10.1002/14651858.CD001843.pub5Anderson C.A., Omar M.I., Campbell S.E., Hunter K.F., Cody J.D., Glazener C.M. Conservative management for postprostatectomy urinary incontinence. Cochrane Database Syst Rev. 2015;1(1):CD001843. DOI: 10.1002/14651858.CD001843.pub5Glazener C., Boachie C., Buckley B., Cochran C., Dorey G., Grant A., Hagen S., Kilonzo M., McDonald A., McPherson G., Moore K., N’Dow J., Norrie J., Ramsay C., Vale L. Conservative treatment for urinary incontinence in Men After Prostate Surgery (MAPS): two parallel randomised controlled trials. Health Technol Assess. 2011;15(24):1-290, iii-iv. DOI: 10.3310/hta15240Glazener C., Boachie C., Buckley B., Cochran C., Dorey G., Grant A., Hagen S., Kilonzo M., McDonald A., McPherson G., Moore K., N’Dow J., Norrie J., Ramsay C., Vale L. Conservative treatment for urinary incontinence in Men After Prostate Surgery (MAPS): two parallel randomised controlled trials. Health Technol Assess. 2011;15(24):1-290, iii-iv. DOI: 10.3310/hta15240Glazener C., Boachie C., Buckley B., Cochran C., Dorey G., Grant A., Hagen S., Kilonzo M., McDonald A., McPherson G., Moore K., Norrie J., Ramsay C., Vale L., N’Dow J. Urinary incontinence in men after formal one-to-one pelvic-floor muscle training following radical prostatectomy or transurethral resection of the prostate (MAPS): two parallel randomised controlled trials. Lancet. 2011;378(9788):328-337. Erratum in: Lancet. 2012;379(9814):412. DOI: 10.1016/S0140-6736(11)60751-4Glazener C., Boachie C., Buckley B., Cochran C., Dorey G., Grant A., Hagen S., Kilonzo M., McDonald A., McPherson G., Moore K., Norrie J., Ramsay C., Vale L., N’Dow J. Urinary incontinence in men after formal one-to-one pelvic-floor muscle training following radical prostatectomy or transurethral resection of the prostate (MAPS): two parallel randomised controlled trials. Lancet. 2011;378(9788):328-337. Erratum in: Lancet. 2012;379(9814):412. DOI: 10.1016/S0140-6736(11)60751-4Tibaek S., Klarskov P., Lund Hansen B., Thomsen H., Andresen H., Schmidt Jensen C., Niemann Olsen M. Pelvic floor muscle training before transurethral resection of the prostate: a randomized, controlled, blinded study. Scand J Urol Nephrol. 2007;41(4):329-334. DOI: 10.1080/00365590601183584Tibaek S., Klarskov P., Lund Hansen B., Thomsen H., Andresen H., Schmidt Jensen C., Niemann Olsen M. Pelvic floor muscle training before transurethral resection of the prostate: a randomized, controlled, blinded study. Scand J Urol Nephrol. 2007;41(4):329-334. DOI: 10.1080/00365590601183584Anan G., Kaiho Y., Iwamura H., Ito J., Kohada Y., Mikami J., Sato M. Preoperative pelvic floor muscle exercise for early continence after holmium laser enucleation of the prostate: a randomized controlled study. BMC Urol. 2020;20(1):3. DOI: 10.1186/s12894-019-0570-5Anan G., Kaiho Y., Iwamura H., Ito J., Kohada Y., Mikami J., Sato M. Preoperative pelvic floor muscle exercise for early continence after holmium laser enucleation of the prostate: a randomized controlled study. BMC Urol. 2020;20(1):3. DOI: 10.1186/s12894-019-0570-5Fink K.G., Huber J., Würnschimmel E., Schmeller N.T. The use of Duloxetine in the treatment of male stress urinary incontinence. Wien Med Wochenschr. 2008;158(3-4):116-118. DOI: 10.1007/s10354-007-0494-7Fink K.G., Huber J., Würnschimmel E., Schmeller N.T. The use of Duloxetine in the treatment of male stress urinary incontinence. Wien Med Wochenschr. 2008;158(3-4):116-118. DOI: 10.1007/s10354-007-0494-7Noordhoff T.C., Finazzi-Agrò E., Scheepe J.R., Blok B.F.M. Outcome and complications of adjustable continence therapy (ProACTTM ) in the treatment of urinary incontinence after transurethral resection of the prostate: A multicenter study. Neurourol Urodyn. 2019;38(4):1111- 1119. DOI: 10.1002/nau.23966Noordhoff T.C., Finazzi-Agrò E., Scheepe J.R., Blok B.F.M. Outcome and complications of adjustable continence therapy (ProACTTM ) in the treatment of urinary incontinence after transurethral resection of the prostate: A multicenter study. Neurourol Urodyn. 2019;38(4):1111- 1119. DOI: 10.1002/nau.23966Angulo J.C., Fonseca J., Esquinas C., Ojea A., Rodríguez A., Rabassa M., Teba F., Escribano G., Cruz F. Adjustable transobturator male system (ATOMS®) as treatment of stress urinary incontinence secondary to transurethral resection of the prostate. Actas Urol Esp (Engl Ed). 2018;42(9):567-573. (In English, Spanish). DOI: 10.1016/j.acuro.2018.05.002Angulo J.C., Fonseca J., Esquinas C., Ojea A., Rodríguez A., Rabassa M., Teba F., Escribano G., Cruz F. Adjustable transobturator male system (ATOMS®) as treatment of stress urinary incontinence secondary to transurethral resection of the prostate. Actas Urol Esp (Engl Ed). 2018;42(9):567-573. (In English, Spanish). DOI: 10.1016/j.acuro.2018.05.002Friedl A., SchneeweissJ., Stangl K., Mühlstädt S., Zachoval R., Hruby S., Gründler T., Kivaranovic D., Fornara P., Lusuardi L., Brössner C. The Adjustable Transobturator Male System in Stress Urinary Incontinence After Transurethral Resection of the Prostate. Urology. 2017;109:184- 189. DOI: 10.1016/j.urology.2017.07.004Friedl A., SchneeweissJ., Stangl K., Mühlstädt S., Zachoval R., Hruby S., Gründler T., Kivaranovic D., Fornara P., Lusuardi L., Brössner C. The Adjustable Transobturator Male System in Stress Urinary Incontinence After Transurethral Resection of the Prostate. Urology. 2017;109:184- 189. DOI: 10.1016/j.urology.2017.07.004Parker D.C., Simhan J. Management of complications after surgical outlet reduction for benign prostatic obstruction. Can J Urol. 2015;22 Suppl 1:88-92. PMID: 26497349Parker D.C., Simhan J. Management of complications after surgical outlet reduction for benign prostatic obstruction. Can J Urol. 2015;22 Suppl 1:88-92. PMID: 26497349Imamoglu M.A., Tuygun C., Bakirtas H., Yiğitbasi O., Kiper A. The comparison of artificial urinary sphincter implantation and endourethral macroplastique injection for the treatment of postprostatectomy incontinence. Eur Urol. 2005;47(2):209-213. DOI: 10.1016/j.eururo.2004.08.019Imamoglu M.A., Tuygun C., Bakirtas H., Yiğitbasi O., Kiper A. The comparison of artificial urinary sphincter implantation and endourethral macroplastique injection for the treatment of postprostatectomy incontinence. Eur Urol. 2005;47(2):209-213. DOI: 10.1016/j.eururo.2004.08.019Silva L.A., Andriolo R.B., Atallah Á.N., da Silva E.M. Surgery for stress urinary incontinence due to presumed sphincter deficiency after prostate surgery. Cochrane Database Syst Rev. 2014;2014(9):CD008306. DOI: 10.1002/14651858.CD008306.pub3Silva L.A., Andriolo R.B., Atallah Á.N., da Silva E.M. Surgery for stress urinary incontinence due to presumed sphincter deficiency after prostate surgery. Cochrane Database Syst Rev. 2014;2014(9):CD008306. DOI: 10.1002/14651858.CD008306.pub3Hogewoning C.R.C., Meij L.A.M., Pelger R.C.M., Putter H., Krouwel E.M., Elzevier H.W. Sling Surgery for the Treatment of Urinary Incontinence After Transurethral Resection of the Prostate: New Data on the Virtue Male Sling and an Evaluation of Literature. Urology. 2017;100:187-192. DOI: 10.1016/j.urology.2016.08.060Hogewoning C.R.C., Meij L.A.M., Pelger R.C.M., Putter H., Krouwel E.M., Elzevier H.W. Sling Surgery for the Treatment of Urinary Incontinence After Transurethral Resection of the Prostate: New Data on the Virtue Male Sling and an Evaluation of Literature. Urology. 2017;100:187-192. DOI: 10.1016/j.urology.2016.08.060Leizour B., Chevrot A., Wagner L., Droupy S., Costa P. Bandelette sousurétrale rétropubienne ajustable Remeex® dans le traitement de l’incontinence urinaire d’effort masculine: résultats à un an [Adjustable retropubic suburethral sling Remeex® in the treatment of male stress urinary incontinence: One-year results]. Prog Urol. 2017;27(4):238-243. (In French) DOI: 10.1016/j.purol.2016.11.006Leizour B., Chevrot A., Wagner L., Droupy S., Costa P. Bandelette sousurétrale rétropubienne ajustable Remeex® dans le traitement de l’incontinence urinaire d’effort masculine: résultats à un an [Adjustable retropubic suburethral sling Remeex® in the treatment of male stress urinary incontinence: One-year results]. Prog Urol. 2017;27(4):238-243. (In French) DOI: 10.1016/j.purol.2016.11.006Constable L., Abrams P., Cooper D., Kilonzo M., Cotterill N., Harding C., Drake M.J., Pardoe M.N., McDonald A., Smith R., Norrie J., McCormack K., Ramsay C., Uren A., Mundy T., Glazener C., MacLennan G. Synthetic sling or artificial urinary sphincter for men with urodynamic stress incontinence after prostate surgery: the MASTER non-inferiority RCT. Health Technol Assess. 2022;26(36):1-152. DOI: 10.3310/TBFZ0277Constable L., Abrams P., Cooper D., Kilonzo M., Cotterill N., Harding C., Drake M.J., Pardoe M.N., McDonald A., Smith R., Norrie J., McCormack K., Ramsay C., Uren A., Mundy T., Glazener C., MacLennan G. Synthetic sling or artificial urinary sphincter for men with urodynamic stress incontinence after prostate surgery: the MASTER non-inferiority RCT. Health Technol Assess. 2022;26(36):1-152. DOI: 10.3310/TBFZ0277

The authors declare that there are no conflicts of interest present.